On May 28, 2021, OIG released its Semiannual Report to Congress (the Report). The Report describes OIG’s work during the 6-month semiannual reporting period of October 1, 2020, through March 31, 2021 (the Semiannual Reporting...more
6/3/2021
/ Audits ,
Centers for Medicare & Medicaid Services (CMS) ,
Coronavirus/COVID-19 ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
Fraud ,
Healthcare Fraud ,
Medicaid ,
Medicare ,
Medicare Part B ,
Medicare Part D ,
OIG ,
Opioid
From December 23, 2020 through December 31, 2020, the OIG issued several advisory opinions. The advisory opinions analyzed (1) a program for a pharmaceutical manufacturer to provide financial assistance to certain patients,...more
1/8/2021
/ Advisory Opinions ,
Anti-Kickback Statute ,
Financial Assistance Policies ,
Food and Drug Administration (FDA) ,
Home Health Agencies ,
Manufacturers ,
Medicare ,
OIG ,
Pharmaceutical Industry ,
Prescription Drugs ,
Preventive Health Care ,
REMS ,
Skilled Nursing Facility